Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GQ-1010 by Biohaven for Epithelial Tumor: Likelihood of Approval
GQ-1010 is under clinical development by Biohaven and currently in Phase II for Epithelial Tumor. According to GlobalData, Phase II...